SCHEMBL30281113

SCHEMBL30281113

CCn1nc(C(=O)O)c(C2CC2(F)F)n1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.35
▸ TEAD1 P28347 1/20 0.31
▸ TEAD4 Q15561 1/20 0.31
▸ TEAD2 Q15562 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20600392 0.68 NPC1 (0.44) NPC1
SCHEMBL30281268 0.67 SMN1; SMN2 (0.36) TEAD1TEAD4TEAD2
SCHEMBL16856709 0.66 NPC1 (0.43) NPC1
SCHEMBL31054928 0.66 — —
SCHEMBL31054856 0.66 — —
SCHEMBL30281156 0.62 — —
SCHEMBL30444863 0.60 HTT (0.39) —
SCHEMBL28976609 0.58 TEAD1 (0.36) TEAD1TEAD4TEAD2
SCHEMBL13267497 0.56 TSHR (0.48) —
SCHEMBL25702335 0.56 NPC1 (0.36) NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143195-A1 IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17 Janssen Pharmaceutica NV (BE) 2023-03-08 — — EP disclosed
Send feedback